A novel high-flow nasal cannula oxygen therapy instrument based on algorithm model to predict intubation accuracy

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100052995

Enrollment

Unknown

Registered

2021-11-07

Start date

2021-11-20

Completion date

Unknown

Last updated

2022-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyoxemia

Interventions

Gold Standard:Clinical outcome

Index test:A&#32

high-flow&#32

cannula&#32

based&#32

on&#32

algorithm&#32

model.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; receiving high-flow oxygen therapy for various reasons, including high-flow initial therapy and sequential therapy after removal of tracheal intubation; 2. With or without type 2 respiratory failure; intermittent or continuous use of high-flow oxygen.

Exclusion criteria

Exclusion criteria: Tracheotomy patients; refusal of tracheal intubation and invasive rescue therapy; patient request to withdraw from the study; incomplete data collection; hospital stay < 48 hours.

Design outcomes

Primary

Measure	Time frame
intubation rate;accuracy, specificity, sensitivity, ROC curve;	—

Countries

China

Contacts

Public ContactLiu Taotao

Beijing Hospital

taotao20022000@163.com+86 13811187465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026